Innate Pharma Ownership | Who Owns Innate Pharma?
Innate Pharma Ownership Summary
Innate Pharma is owned by 0.10% institutional investors, and 99.90% retail investors. Exchange traded concepts is the largest institutional shareholder, holding 0.10% of IPHA shares. Range Cancer Therapeutics ETF is the top mutual fund, with 0.09% of its assets in Innate Pharma shares.
IPHA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Innate Pharma | 0.10% | - | 99.90% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Exchange traded concepts | 77.35K | 0.10% | $143.10K |
| Morgan stanley | 43.52K | 0.05% | $84.44K |
| Citadel advisors | 23.53K | 0.03% | $45.64K |
| Ubs group | 3.51K | 0.00% | $6.46K |
| Rhumbline advisers | 675.00 | 0.00% | $1.25K |
| National bank of canada /fi/ | 450.00 | 0.00% | $828.00 |
| Barclays | 307.00 | 0.00% | $1.00K |
| Steward partners investment advisory | 200.00 | 0.00% | $368.00 |
| Optiver b.v. | 101.00 | 0.00% | $187.00 |
| Millennium management | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Exchange traded concepts | 77.35K | 0.00% | $143.10K |
| Barclays | 307.00 | - | $1.00K |
| Optiver b.v. | 101.00 | - | $187.00 |
| Steward partners investment advisory | 200.00 | - | $368.00 |
| Jane street group | - | - | - |
| National bank of canada /fi/ | 450.00 | - | $828.00 |
| Millennium management | - | - | - |
| Ubs group | 3.51K | - | $6.46K |
| Citadel advisors | 23.53K | - | $45.64K |
| Morgan stanley | 43.52K | - | $84.44K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Citadel advisors | 23.53K | - | 23.53K |
| Rhumbline advisers | 675.00 | - | 470.00 |
| National bank of canada /fi/ | 450.00 | - | 450.00 |
| Barclays | 307.00 | - | - |
| Steward partners investment advisory | 200.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Optiver b.v. | 101.00 | - | -86.69K |
| Jane street group | - | - | -14.55K |
| Millennium management | - | - | -10.58K |
| Ubs group | 3.51K | - | -4.90K |
| Morgan stanley | 43.52K | - | -600.00 |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Citadel advisors | 23.53K | - | 23.53K | $45.64K |
| National bank of canada /fi/ | 450.00 | - | 450.00 | $828.00 |
Sold Out
| Holder | Change |
|---|---|
| Millennium management | -10.58K |
| Jane street group | -14.55K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 5 | -37.50% | 78,982 | -66.82% | - | 111.34% | 2 | 100.00% | - | -100.00% |
| Sep 30, 2024 | 8 | - | 238,049 | -1.53% | - | 330.02% | 1 | -66.67% | 4 | 100.00% |
| Jun 30, 2024 | 8 | -11.11% | 241,754 | -4.79% | - | 301.68% | 3 | -25.00% | 2 | - |
| Mar 31, 2024 | 9 | 12.50% | 253,918 | 96.97% | - | 1240.88% | 4 | 100.00% | 2 | -33.33% |
| Dec 31, 2023 | 8 | - | 128,912 | -59.51% | - | 102.15% | 2 | 100.00% | 3 | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Range Cancer Therapeutics ETF | 72.69K | 0.09% | - |
| ActivePassive International Equity ETF | 37.49K | 0.05% | 132.00 |
IPHA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools